Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clemens Giegerich

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Chemical Information and Modeling|July 17, 2012
MARS: computing three-dimensional alignments for multiple ligands using pairwise similaritiesThomas Klabunde, Clemens Giegerich, Andreas Evers
Journal of Medicinal Chemistry|April 21, 2009
Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screeningThomas Klabunde, Clemens Giegerich, Andreas Evers
CPT: Pharmacometrics & Systems Pharmacology|April 23, 2026
Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time ProfilesFelix Jost, Clemens Giegerich, Christoph Grebner, et al.
IEEE Transactions on Bio-Medical Engineering|June 1, 2019
Modeling Subcutaneous Absorption of Long-Acting Insulin Glargine in Type 1 DiabetesMichele Schiavon, Roberto Visentin, Clemens Giegerich, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 17, 2018
Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator<sup>.</sup>Roberto Visentin, Michele Schiavon, Clemens Giegerich, et al.
IEEE Transactions on Bio-Medical Engineering|February 9, 2019
Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 Diabetes Simulator for In Silico Testing of MDI TherapiesRoberto Visentin, Michele Schiavon, Clemens Giegerich, et al.
Bioorganic & Medicinal Chemistry|May 8, 2012
Development of in silico filters to predict activation of the pregnane X receptor (PXR) by structurally diverse drug-like moleculesHans Matter, Lennart T Anger, Clemens Giegerich, et al.
Diabetes Technology & Therapeutics|March 4, 2020
<i>In Silico</i> Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 DiabetesMichele Schiavon, Roberto Visentin, Clemens Giegerich, et al.
Frontiers in Systems Biology|August 14, 2025
Building virtual patients using simulation-based inferenceNathalie Paul, Venetia Karamitsou, Clemens Giegerich, et al.
Molecular Informatics|July 29, 2016
Identification and Application of Antitarget Activity Hotspots to Guide Compound OptimizationGerhard Hessler, Hans Matter, Friedemann Schmidt, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Chemical Information and Modeling|July 17, 2012
MARS: computing three-dimensional alignments for multiple ligands using pairwise similaritiesThomas Klabunde, Clemens Giegerich, Andreas Evers
Journal of Medicinal Chemistry|April 21, 2009
Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screeningThomas Klabunde, Clemens Giegerich, Andreas Evers
CPT: Pharmacometrics & Systems Pharmacology|April 23, 2026
Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time ProfilesFelix Jost, Clemens Giegerich, Christoph Grebner, et al.
IEEE Transactions on Bio-Medical Engineering|June 1, 2019
Modeling Subcutaneous Absorption of Long-Acting Insulin Glargine in Type 1 DiabetesMichele Schiavon, Roberto Visentin, Clemens Giegerich, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 17, 2018
Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator<sup>.</sup>Roberto Visentin, Michele Schiavon, Clemens Giegerich, et al.
IEEE Transactions on Bio-Medical Engineering|February 9, 2019
Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 Diabetes Simulator for In Silico Testing of MDI TherapiesRoberto Visentin, Michele Schiavon, Clemens Giegerich, et al.
Bioorganic & Medicinal Chemistry|May 8, 2012
Development of in silico filters to predict activation of the pregnane X receptor (PXR) by structurally diverse drug-like moleculesHans Matter, Lennart T Anger, Clemens Giegerich, et al.
Diabetes Technology & Therapeutics|March 4, 2020
<i>In Silico</i> Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 DiabetesMichele Schiavon, Roberto Visentin, Clemens Giegerich, et al.
Frontiers in Systems Biology|August 14, 2025
Building virtual patients using simulation-based inferenceNathalie Paul, Venetia Karamitsou, Clemens Giegerich, et al.
Molecular Informatics|July 29, 2016
Identification and Application of Antitarget Activity Hotspots to Guide Compound OptimizationGerhard Hessler, Hans Matter, Friedemann Schmidt, et al.
Pageof 2